Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

Hypertension

Volumn 40, Issue 3, 2002, Pages 355-360

  Watanabe, Susumu ^a   Kang, Duk Hee ^a   Feng, Lili ^a   Nakagawa, Takahiko ^a   Kanellis, John ^a   Lan, Hui ^a   Mazzali, Marilda ^a   Johnson, Richard J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hypertension, sodium dependent; Mutation; Renal disease; Uric acid

Indexed keywords

CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; RENIN; URATE OXIDASE; URIC ACID;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; EPIDEMIC; EVOLUTION; GENE MUTATION; HOMINID; HUMAN; HYPERTENSION; HYPERURICEMIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SODIUM INTAKE; SODIUM RESTRICTION; SURVIVAL; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CELL DIVISION; CELLS, CULTURED; DEVELOPED COUNTRIES; EVOLUTION, MOLECULAR; HUMANS; HYPERTENSION; KIDNEY DISEASES; KINETICS; MODELS, CARDIOVASCULAR; MUSCLE, SMOOTH, VASCULAR; MUTATION; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY; URATE OXIDASE; URIC ACID;

EID: 0036713048     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000028589.66335.AA     Document Type: Review

References (42)

1. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991
2. National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly
3. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
4. Blood pressure and end-stage renal disease in men
5. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis
6. The Hypertension Optimal Treatment study and the importance of lowering blood pressure
7. Nutrition and civilization
8. Possible role of salt intake in the development of essential hypertension
9. Salt and hypertension. Lessons from animal models that relate to human hypertension
10. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture
11. Paleolithic nutrition
12. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension
13. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism
14. Hyperuricemia induces a primary arteriolpathy in rats by a blood pressure-independent mechanism
15. Two independent mutational events in the loss of urate oxidase during hominoid evolution
16. Generation time and genomic evolution in primates
17. The phylogeny of the hominoid primates, as indicated by DNA-DNA hybridization
18. Urate oxidase in primate phylogenesis
19. Molecular Evolution '99. The genomic record of humankind's evolutionary roots
20. Man: Sapient but gouty
21. Evolution and environment in the Hominoidea
22. Genetic and morphological records of the Hominoidea and hominid origins: A synthesis
23. Hominoid dietary evolution
24. Hominoid evolution and environmental change in the Neogene of Europe: A European Science Foundation network
25. Geology and palaeontology of the Late Miocene Middle Awash valley, Afar rift, Ethiopia
26. Positive selection of a gene family during the emergence of humans and African apes
27. Climbing, brachiation and terrestrial quadrupedalism: Historical precursors of hominid bipedalism
28. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis
29. Serum uric acid and hypertension: The Olivetti heart study
30. Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries
31. Hyperuricemia in primary and renal hypertension
32. The renal origin of hypertension
33. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension
34. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression
35. Serum uric acid and cardiovascular events in successfully treated hypertensive patients
36. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study
37. Racial differences in the incidence of gout
38. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease
39. Risk factors for cardiovascular disease: One down, many more to evaluate
40. Uric acid: A risk factor for coronary artery disease
41. Effect of angiotensin and norepinephrine upon urate clearance in man